Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
⏳ Can we measure aging before disease arrives? A fascinating Nature Medicine analysis puts epigenetic aging clocks to the test. Across 51 intervention studies and 3,128 blood samples, reliable next-generation clocks—particularly DunedinPACE and PCGrimAge—were the most responsive. 🧬 Pharmacologic interventions generated especially strong signals. Responsiveness of epigenetic aging biomarkers to longevity interventions in humans.pdf But here is the clinical pearl: a clock moving backward does not yet prove that the patient will live longer or healthier. ⚠️ Responsiveness is...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 Why do some people reach 100+ with remarkable resilience? Centenarians don’t simply escape immune aging—they appear to adapt to it. Preserved NK-cell function, altered T-cell populations, delayed autophagy decline, modulation of inflammageing, and distinctive transcriptomic, epigenetic and gut-microbial signatures may help maintain immune homeostasis. 💯🛡️ Fascinating lessons from nature’s longest-lived humans—and perhaps clues for extending healthspan, not merely lifespan. 🔬♻️
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🎨 Repigment, Reframe, Restore: A New Era for Vitiligo Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. 💊 But here is the deeper lesson: better pigmentation ≠ complete patient benefit. Only 13–15% reported their vitiligo as “a lot less” or “no longer” noticeable. 👁️ The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. 🧠❤️ #Vitiligo #Dermatology #JAKInhibitors...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 Detect, Decode, Decide: The Promise of Liquid Biopsy Can a blood test tell us what cancer is doing before imaging can? 🩸 Circulating tumor DNA (ctDNA) can identify actionable variants, track treatment response, detect resistance, and reveal molecular residual disease. In colorectal cancer, molecular relapse was detected ~8.7 months earlier than with imaging surveillance. 🔬 But important questions remain: when should we test, how often, and should ctDNA positivity alone trigger treatment?
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩺 Great Doctors Series: Rhazes (c. 865–925 CE) More than 1,000 years ago, Persian physician Rhazes (Al-Razi) practiced a remarkably modern kind of medicine: observe the patient, question authority, compare outcomes, and care for everyone—rich or poor. 🔬 He distinguished smallpox from measles, pioneered writing on childhood disease, challenged Galen when observations disagreed, and profoundly influenced medical education in Europe. 📚🌍 His timeless prescription? Observe carefully. Question courageously. Care compassionately. ⚕️
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
⚡ Short Sprints, Big Signals: How Exercise Intensity Changes the Message Exercise may be more than movement—it may be an interorgan conversation. 🧬🫀 A fascinating human multi-omics study shows that sprint-interval exercise produces broader and faster changes in circulating proteins and metabolites than moderate-intensity exercise. Muscle and adipose tissue appear central to this molecular dialogue, while many sprint-responsive proteins are associated with favorable cardiometabolic outcomes. 💡 Perhaps exercise intensity is not simply “more effort”—it is a different biological...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧠❤️ The aging heart does not age alone. The 2026 ACC Scientific Statement reminds us that cardiovascular disease, cognitive impairment, and frailty are intertwined manifestations of biological aging. Cognitive Impairment and Frailty in Older Adults With Cardio vascular Disease- 2026 ACC Scientific Statement.pdf For clinicians, the message is practical: 🔍 screen cognition and frailty, 🚶 assess gait and strength, 🏋️ build resilience through multidomain exercise, 🥗 optimize nutrition, and 💊 reduce unnecessary medication burden. ❤️ The goal is bigger than...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🫀 The infarct ends. The risk doesn’t. After myocardial infarction, atherosclerosis, thrombosis, inflammation, depression, deconditioning—and declining adherence—can sustain risk for decades. Our editorial proposes Persistent Prevention: 🔄 reassess evolving risk, 🎯 treat residual risk, 💊 sustain therapy when indicated, 🏃 prioritize cardiac rehabilitation, and 🧠 address psychosocial health. The goal: move from a static discharge bundle to a dynamic, lifelong prevention plan. ❤️ #Cardiology #MyocardialInfarction #Prevention
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧠🔀 Blend, Switch, Pursue: How the Brain Juggles Goals Must we choose one goal at a time? Apparently not. A fascinating Nature study suggests the brain continuously blends competing goals. 🎯 Using control theory and human intracranial recordings, investigators reveal a striking division of labor: 🧭 hippocampus estimates and updates the policy state, 🔀 anterior cingulate cortex anticipates major switches, and ⚖️ orbitofrontal cortex provides value context. A compelling bridge between engineering, neuroscience, and real-world executive behavior. 🧠⚙️
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧠 Can we “replumb” the brain to fight Alzheimer’s? A provocative procedure—deep cervical lymphatic–venous anastomosis (dcLVA)—connects neck lymphatics to veins in an attempt to enhance brain-waste clearance. Early reports describe improvements in cognition and biomarkers, but the evidence remains limited and durability uncertain. A controversial Alzheimer’s surgery is said to reverse symptoms — here’s what scientists know _ Nature.pdf 🔬 Randomized and even sham-controlled trials are now putting this extraordinary hypothesis to the test.
info_outline⏳ Can we measure aging before disease arrives?
A fascinating Nature Medicine analysis puts epigenetic aging clocks to the test. Across 51 intervention studies and 3,128 blood samples, reliable next-generation clocks—particularly DunedinPACE and PCGrimAge—were the most responsive. 🧬 Pharmacologic interventions generated especially strong signals.
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans.pdf
But here is the clinical pearl: a clock moving backward does not yet prove that the patient will live longer or healthier. ⚠️ Responsiveness is necessary for surrogacy—but not sufficient.
News and Views Putting epigenetic aging clocks on trial.pdf
🎙️ Dr RR Baliga’s Podkast for the Kurious Doc. Where Curiosity Meets Clarity!